Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion type Assertion NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_head.
- NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion wasGeneratedBy ECO_0000203 NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_provenance.
- NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion wasDerivedFrom befree-20140225 NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_provenance.
- NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion SIO_000772 20683028 NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_provenance.
- NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion evidence source_evidence_literature NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_provenance.
- NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_assertion description "[The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP199887.RAn4xRTO9K_GHEgDgYri_95CeFQtcoC6PH2rLUmi1VOhQ130_provenance.